Nuvation Bio Inc.
USD4.92
+0.16 (+3.36%)
CEO
David T. Hung
IPO Date
2020-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$4.86
Prev. Close
$4.76
Day Low
$4.86
Day High
$5.21
52W Low
$1.57
52W High
$9.75
Market Cap
$1.71B
Volume
5.25M
| -1.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -12.5% | -12.2% | 0.01 | 44.11 | -4.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -15.9% | -15.5% | 0.01 | 50.70 | -4.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -11.6% | -11.2% | 0.00 | 45.62 | -19.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -19.4% | -18.8% | 0.00 | 33.69 | -61.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -28.5% | -27.7% | 0.00 | 37.42 | -61.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 133.3% | -627.8% | -0.81 | 0.18 | -1852.2 |
| -21.1 |
| 30 Sept 2025 | Q3 | 74.5% | -425.2% | -17.1% | -9.3% | 0.18 | 8.48 | -5.7 |
| 30 Jun 2025 | Q2 | 46.7% | -1220.9% | -15.8% | -9.1% | 0.15 | 9.39 | -2.8 |
| 31 Mar 2025 | Q1 | 32.1% | -1726.2% | -12.7% | -10.8% | 0.03 | 9.01 | -2.8 |
| 31 Dec 2024 | Q4 | 26.2% | -865.8% | -10.7% | -9.1% | 0.02 | 9.04 | -4.5 |
| 30 Sept 2024 | Q3 | -108.4% | -5668.5% | -8.2% | -7.2% | 0.02 | 9.57 | -3.8 |
| 30 Jun 2024 | Q2 | 6.1% | -32229.4% | -179.8% | -77.8% | 0.06 | 11.49 | -0.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -2.5% | -2.4% | 0.01 | 38.58 | -13.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -2.3% | -2.2% | 0.01 | 44.11 | -6.0 |